NCT03894410已完成不适用
Real World Study of Lapatinib Among Metastatic Breast Cancer Patients in Clinical Practice: a Multicenter, Retrospective Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 242
- 试验地点
- 1
- 主要终点
- Number of participants with treatment-related adverse events as assessed by Common Terminology Criteria for Adverse Events version 4.0 (CTCAE v4.0)
研究概览
简要总结
A multicenter, retrospective, real world study of Lapatinib among Metastatic Breast Cancer (MBC) Patients in Clinical Practice.
详细描述
This study collected patients used Lapatinib-base therapy among MBC, and tried to figure out if there was difference between single anti-Her2 treatment and dual anti-Her2 treatment. Furthermore, this study investigated the treatment after Lapatinib.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Patients who were treated with Lapatinib between June 2014 to June
- •Patients experienced progression on prior trastuzumab-containing regimens and a taxane.
- •Complete medical history was available.
排除标准
- •Medical history was incomplete.
结局指标
主要结局
Number of participants with treatment-related adverse events as assessed by Common Terminology Criteria for Adverse Events version 4.0 (CTCAE v4.0)
时间窗: 6 weeks
PFS
时间窗: 6 weeks
Progression free survival
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
2 期
Clinical Study of Apatinib Combined With SBRT Therapy in the Treatment of Oligometastasis of Breast CancerBreast CancerNCT03457467Yan Li30
已完成
4 期
A Randomized, Open-label, Multi-center Phase IV Study Evaluating Palbociclib Plus Endocrine Treatment Versus a Chemotherapy-based Treatment Strategy in Patients With Hormone Receptor Positive / HER2 Negative Breast Cancer in a Real World Setting (GBG 93 - PADMA Study).Metastatic Breast CancerNCT03355157German Breast Group130
终止
1 期
BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreaticobiliary CancerMetastatic Pancreatic CancerNCT00447122Brown University25
进行中（未招募）
2 期
Olaparib In Metastatic Breast CancerSomatic Mutation Breast Cancer (BRCA1)Somatic Mutation Breast Cancer (BRCA2)CHEK2 Gene MutationMetastatic Breast CancerInvasive Breast CancerATM Gene MutationPALB2 Gene MutationRAD51 Gene MutationBRIP1 Gene MutationNBN Gene MutationNCT03344965Beth Israel Deaconess Medical Center114
终止
2 期
Sitravatinib in Metastatic Breast CancerBreast Cancer Stage IVTriple Negative Breast CancerBreast NeoplasmsBreast Cancer MetastaticNCT04123704Xiang Zhang3